Damora Therapeutics (DMRA) Preferred Dividend Payments (2019 - 2020)

Damora Therapeutics (DMRA) posted Preferred Dividend Payments of $2.7 million for Q3 2020, up 93.65% on a QoQ basis from $1.4 million in Q4 2019, and up 93.65% year-over-year from $1.4 million in Q4 2019.

Damora Therapeutics (DMRA) Preferred Dividend Payments (2019 - 2020) Analysis & Trends

Damora Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $2.7 million for Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Damora Therapeutics 1.00 Bn 798.11 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2020 2.71 Mn
Dec 31, 2019 1.40 Mn
Sep 30, 2019 1.40 Mn